JUVÉDERM® VOLUX™ XC IS THE FIRST AND ONLY HYALURONIC ACID (HA) FILLER TO RECEIVE U.S. FDA APPROVAL FOR IMPROVING JAWLINE DEFINITION IRVINE, Calif., Aug. 3, 2022 /PRNewswire/ -- Today, Allergan ...
At 3 months, findings showed 80.4% of patients treated with Juvéderm Voluma XC achieved at least a 1-point improvement in moderate to severe temple hollowing. The Food and Drug Administration (FDA) ...
I have genetically flat cheeks and undereye hollowing that I’d like to change, so cheek filler has piqued my interest. Still, before I book in for my own consultation, I have a lot of questions best ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results